|
|
J Neurol Neurosurg Psychiatry. 1996 October; 61(4): 376–380. | PMCID: PMC486578 |
Platelets, alcohol consumption, and onset of brain infarction. H Numminen, M Hillbom, and S Juvela Department of Neurology, Oulu University Hospital, Finland. Abstract OBJECTIVES: Previous investigations have suggested that recurrent rebound thrombocytosis after alcohol misuse may be a factor in the pathogenesis of thromboembolic disease. Alcohol consumption, platelet count, and platelet function were examined among patients of working age with brain infarction. METHODS: Platelet count and risk factors for stroke were studied in 426 stroke patients and 157 control patients in hospital. The measures were platelet count obtained within four days after the stroke onset, in vitro adenosine diphosphate induced platelet aggregation, associated thromboxane B2 formation, and urinary excretion of 11-dehydrothromboxane B2. RESULTS: After adjustment for sex, age, cardiac disease, diabetes, and alcohol intake, hypertension (OR 3.4, 95% confidence interval (95% CI) 2.0-6.0) and current smoking (OR 2.1, 95% CI 1.4-3.3) were associated with an increased risk for brain infarction. Platelet count shortly after the onset of disease was higher in the stroke patients than in the controls (OR 1.05/10(10)/1 platelets; 95% CI 1.02-1.09). The patients with brain infarction who were heavy alcohol drinkers (n = 144) showed both thrombocytosis (OR 2.30, 95% CI 0.82-6.44) and thrombocytopenia (OR 3.20, 95% CI 1.19 to 8.59) more often at the onset of the stroke than the other patients with brain infarction. The thromboxane variables showed inconsistent associations with the onset of stroke. There was no consistent platelet abnormality among alcohol misusers at the onset of ischaemic brain infarction. CONCLUSIONS: Alcohol induced thrombocytopenia and rebound thrombocytosis were both often seen at the onset of brain infarction in patients who were heavy alcohol drinkers. Therefore, other mechanisms which could contribute to the high frequency of recurrences of ischaemic stroke among heavy drinkers should be investigated. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (981K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - SULLIVAN LW, HERBERT V. SUPPRESSION HEMATOPOIESIS BY ETHANOL. J Clin Invest. 1964 Nov;43:2048–2062. [PubMed]
- Haselager EM, Vreeken J. Rebound thrombocytosis after alcohol abuse: a possible factor in the pathogenesis of thromboembolic disease. Lancet. 1977 Apr 9;1(8015):774–775. [PubMed]
- Gill JS, Zezulka AV, Shipley MJ, Gill SK, Beevers DG. Stroke and alcohol consumption. N Engl J Med. 1986 Oct 23;315(17):1041–1046. [PubMed]
- Hillbom M, Haapaniemi H, Juvela S, Palomäki H, Numminen H, Kaste M. Recent alcohol consumption, cigarette smoking, and cerebral infarction in young adults. Stroke. 1995 Jan;26(1):40–45. [PubMed]
- Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994 Apr;44(4):626–634. [PubMed]
- Bush B, Shaw S, Cleary P, Delbanco TL, Aronson MD. Screening for alcohol abuse using the CAGE questionnaire. Am J Med. 1987 Feb;82(2):231–235. [PubMed]
- Catella F, Healy D, Lawson JA, FitzGerald GA. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci U S A. 1986 Aug;83(16):5861–5865. [PubMed]
- Ciabattoni G, Pugliese F, Davi G, Pierucci A, Simonetti BM, Patrono C. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. Biochim Biophys Acta. 1989 Jul 21;992(1):66–70. [PubMed]
- Papoz L, Warnet JM, Péquignot G, Eschwege E, Claude JR, Schwartz D. Alcohol consumption in a healthy population. Relationship to gamma-glutamyl transferase activity and mean corpuscular volume. JAMA. 1981 May 1;245(17):1748–1751. [PubMed]
- Tohgi H, Suzuki H, Tamura K, Kimura B. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke. 1991 Jan;22(1):17–21. [PubMed]
- O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in stroke patients. Stroke. 1995 Jun;26(6):995–999. [PubMed]
- Valkila EH, Salenius JP, Koivula TA. Platelet indices in patients with occlusive carotid artery disease. Angiology. 1994 May;45(5):361–365. [PubMed]
- Syrjänen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed). 1988 Apr 23;296(6630):1156–1160. [PubMed]
- Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, Rohlfs M, Suhr H, Fiehn W, Becher H, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke. 1995 Mar;26(3):373–379. [PubMed]
- Dougherty JH, Jr, Levy DE, Weksler BB. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease. Lancet. 1977 Apr 16;1(8016):821–824. [PubMed]
- Mulley GP, Heptinstall S, Taylor PM, Mitchell JR. ADP-induced platelet release reaction in acute stroke. Thromb Haemost. 1983 Aug 30;50(2):524–526. [PubMed]
- Koudstaal PJ, Ciabattoni G, van Gijn J, Nieuwenhuis HK, de Groot PG, Sixma JJ, Patrono C. Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke. 1993 Feb;24(2):219–223. [PubMed]
- Uchiyama S, Yamazaki M, Maruyama S, Handa M, Ikeda Y, Fukuyama M, Itagaki I. Shear-induced platelet aggregation in cerebral ischemia. Stroke. 1994 Aug;25(8):1547–1551. [PubMed]
- van Kooten F, Ciabattoni G, Patrono C, Schmitz PI, van Gijn J, Koudstaal PJ. Evidence for episodic platelet activation in acute ischemic stroke. Stroke. 1994 Feb;25(2):278–281. [PubMed]
- Liu L, Lin Z, Shen Z, Zhang G, Li S, Cao P. Platelet hyperfunction exists in both acute non-haemorrhagic and haemorrhagic stroke. Thromb Res. 1994 Aug 15;75(4):485–490. [PubMed]
- Preston FE, Martin JF, Stewart RM, Davies-Jones GA. Thrombocytosis, circulating platelet aggregates, and neurological dysfunction. Br Med J. 1979 Dec 15;2(6204):1561–1563. [PubMed]
- Uchiyama S, Takeuchi M, Osawa M, Kobayashi I, Maruyama S, Aosaki M, Hirosawa K. Platelet function tests in thrombotic cerebrovascular disorders. Stroke. 1983 Jul–Aug;14(4):511–517. [PubMed]
- Casto L, Camerlingo M, Finazzi G, Censori B, Barbui T, Mamoli A. Essential thrombocytemia and ischemic stroke: report of six cases. Ital J Neurol Sci. 1994 Oct;15(7):359–362. [PubMed]
- Arboix A, Besses C, Acín P, Massons JB, Florensa L, Oliveres M, Sans-Sabrafen J. Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases. Stroke. 1995 Aug;26(8):1463–1466. [PubMed]
- Heptinstall S, Cockbill SR, Burgess-Wilson ME, Jones EW. Studies on platelets before and after stroke in a patient with essential thrombocythaemia. Br Med J (Clin Res Ed). 1988 May 7;296(6632):1298–1299. [PubMed]
- Crowley JJ, Hannigan M, Daly K. Reactive thrombocytosis and stroke following cardiopulmonary bypass surgery: case report on three patients. Eur Heart J. 1994 Aug;15(8):1144–1146. [PubMed]
- Neiman J. Association of transient ischaemic attack in alcohol withdrawal with changes in haemostasis. Br J Addict. 1988 Dec;83(12):1457–1459. [PubMed]
- Levin J, Bessman JD. The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age. J Lab Clin Med. 1983 Feb;101(2):295–307. [PubMed]
- Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol. 1982 Mar;50(3):509–519. [PubMed]
- Mikhailidis DP, Jenkins WJ, Barradas MA, Jeremy JY, Dandona P. Platelet function defects in chronic alcoholism. Br Med J (Clin Res Ed). 1986 Sep 20;293(6549):715–718. [PubMed]
|